Clinical Trials
3 trialsNCT02143466 2026-04-24
AZD9291 in Combination With Ascending Doses of Novel Therapeutics
AstraZeneca
Phase 1 Active not recruiting
NCT05777603 2026-04-09
Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT03452150 2023-04-25
D-0316 First Time in Patients Ascending Dose Study
InventisBio Co., Ltd
Phase 1 Completed